The investigation determined that lower than expected vitros nt-pro-bnp (ntbnp) results were obtained from a non-vitros (biorad) quality control fluid when tested on a vitros xt7600 integrated system.The most likely assignable cause could not be determined with the information currently available.There was no data suggesting an instrument malfunction contributed to the event, however, diagnostic within-run precision testing that would assess the performance of the vitros xt7600 system was not performed by the customer, as requested.Therefore, a transient instrument related issue cannot be completely ruled out.A vitros ntbnp lot 2590 reagent related issue cannot be completely ruled out, however, the customer processed minimal replicates of patient samples with known ntbnp concentrations and the replicate results obtained from each patient sample are consistent and there are no lower or higher than expected results obtained.In addition, when the lower than expected quality control results were removed from the historical quality control results accuracy and precision was acceptable.However, a reagent related issue cannot be completely ruled out as a vitros ntbnp within-run precision test was not performed by the customer as requested.Continual tracking and trending of complaints has not identified any signals that would point to a potential systemic issue with vitros ntbnp reagent lot 2590.Improper sample handling protocol by the customer cannot be ruled out as contributing to the event.The customer did not provide any information concerning the sample handling protocols used when processing the biorad quality control fluids, therefore, it is unknown if the customer is using good laboratory practices when processing the quality controls.(b)(4).
|
A customer obtained lower than expected vitros nt-pro-bnp (ntbnp) results from a non-vitros (biorad) quality control fluid when tested on a vitros xt7600 integrated system.Vitros ntbnp, biorad l3 result of 3885.3 and 1555.5 pg/ml versus the expected result (baseline mean) of 5319.6 pg/ml biased results of the direction and magnitude observed may lead to inappropriate physician action if undetected.The lower than expected vitros ntbnp results were obtained from a non-patient fluid.However, the investigation could rule out that patient samples had not or would not be affected if the event should recur undetected.Ortho was not made aware of any allegation of actual patient harm as a result of the event.This report corresponds to ortho clinical diagnostics inc (ortho) complaint numbers (b)(4).
|